comparemela.com

Latest Breaking News On - Medical oncology department - Page 1 : comparemela.com

Lurbinectedin Plus Irinotecan Is Safe, Prolongs Responses in High-Risk, Pretreated SCLC

Clinical benefit generated from treatment with lurbinectedin plus irinotecan was noted across sensitive and resistant patient populations with SCLC.

Luisg pazOncology departmentMedical oncology departmentHospital universitarioUniversidad complutense de madrid

Neoadjuvant Sacituzumab Govitecan Displays Activity in Muscle-Invasive Bladder Cancer, But Questions Remain

Neoadjuvant sacituzumab govitecan demonstrated efficacy in patients with muscle-invasive bladder cancer, but its future role in the space is uncertain.

Thomas powlesAntonio cigliolaOncology departmentBarts cancer centre at stMedical oncology departmentRaffaele hospitalGenitourinary oncologyBarts cancer centre

Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer

Ipatasertib plus trastuzumab and pertuzumab as frontline maintenance therapy was effective and safe in PIK3CA-mutant, HER2-positive advanced breast cancer.

Comunidad autonoma de catalunaIsrael generalDaiichi sankyo astrazenecaMafalda oliveiraBreast cancer congressHebron university hospitalBreast cancer groupHebron institute of oncologyOncology department of the breast cancer groupAyala pharmaceuticalsMedical oncology departmentUniversity hospitalHebron instituteZenith epigeneticsCureos scienceRelay therapeutics

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Oncology departmentBreast cancer annual congressMontpellier cancer instituteCancer annual congressMedical oncology department

J&J: positive CHMP opinion for lung cancer

J&J: positive CHMP opinion for lung cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nicolas girardInstitut curieHead of the medical oncology departmentProfessor nicolas girardMedical oncology departmentThoracic oncologyRespiratory medicineParis saclay

vimarsana © 2020. All Rights Reserved.